While the findings have to be replicated in other, contemporary cohorts, in 2016, Syeda et al.91 reported that variable PITX2 expression not only modulated atrial resting membrane potential but also confirmed the clinical observation that flecainide was more effective at suppressing AF than sotalol in Pitx2c+/− mice. Here, PITX2 is linked to atrial fibrillation.